Products and services > API
Product Name |
CAS No. |
Quality Standard |
Indication |
---|---|---|---|
53164-05-9 | EP | Non-steroidal anti-inflammatory drug | |
97540-22-2 | IN HOUSE | Liver protection | |
101020-79-5 | IN HOUSE | Liver protection | |
19774-82-4 | EP | Antiarrhythmic drug | |
503612-47-3 | IN HOUSE | Anti-thrombotic | |
14919-77-8 | EP | Decarboxylase inhibitor | |
202189-78-4 | IN HOUSE | Antihistamines | |
151756-26-2 | IN HOUSE | Expectorants | |
52214-84-3 | EP | Hyperlipidemia | |
201530-41-8 | IN HOUSE | Iron chelating agent | |
138530-94-6 | IN HOUSE | GRED | |
496775-61-2 | IN HOUSE | Thrombocytopenia | |
81161-17-3 | IN HOUSE | Selective beta1-blockers | |
269055-15-4 | IN HOUSE | Anti-HIV | |
259793-96-9 | IN HOUSE | Antiviral | |
49562-28-9 | EP/USP | Hyperlipidemia | |
93479-97-1 | EP | Sulfonylurea antidiabetic | |
391208-81-4 | JPC 2002 | Dermatological medication | |
89-57-6 | EP | Antiulcer drug | |
1094-61-7 | IN HOUSE | anti-aging, neuroprotection, and metabolic improvement | |
223673-61-8 | IN HOUSE | Selective β3-adrenergic receptor agonist | |
26095-59-0 | IN HOUSE | Anti-epileptic | |
380917-97-5 | IN HOUSE | AEDs | |
103177-37-3 | JP | Bronchial asthma drug | |
936623-90-4 | IN HOUSE | Heart failure medicine | |
361442-04-8 | IN HOUSE | Diabetes | |
59804-37-4 | EP | Non-steroidal anti-inflammatory drugs | |
53885-35-1 | JP | Antiplatelet aggregation drug | |
540737-29-9 | IN HOUSE | Rheumatoid Arthritis | |
274901-16-5 | IN HOUSE | Diabetes | |
1404-93-9 | EP/USP | Antibiotic | |
1260141-27-2 | IN HOUSE | GRED | |
625115-55-1 | IN HOUSE | CTEPH | |
808118-40-3 | IN HOUSE | HIF- PHI | |
638-23-3 | IN HOUSE | Expectorants | |
123663-49-0 | IN HOUSE | Anti-rheumatic | |
172152-36-2 | IN HOUSE | GRED | |
35457-80-8 | CP/JP | ANTI-VIRUS | |
72909-34-3 | IN HOUSE | Improve Immunity |